Medpace Holdings Is Maintained at Hold by Truist Securities
Medpace Hldgs Analyst Ratings
Redburn Atlantic Initiates Medpace Holdings at Buy With $404 Price Target
Truist Financial Maintains Medpace(MEDP.US) With Hold Rating, Cuts Target Price to $397
UBS Downgrades Medpace(MEDP.US) to Hold Rating, Cuts Target Price to $350
Maintaining Hold on Medpace Holdings Amid Market Headwinds and Revised Growth Expectations
Medpace Hldgs Analyst Ratings
Jefferies Downgrades Medpace Holdings to Hold From Buy, Price Target Is $345
Medpace Holdings Is Maintained at Outperform by Baird
Baird Maintains Medpace(MEDP.US) With Buy Rating, Cuts Target Price to $413
Medpace Hldgs Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF) and Medpace Holdings (MEDP)
Truist Financial Maintains Medpace(MEDP.US) With Hold Rating, Maintains Target Price $415
Truist Financial Initiates Medpace(MEDP.US) With Hold Rating, Announces Target Price $415
Medpace Hldgs Analyst Ratings
Truist Securities Initiates Coverage On Medpace Hldgs With Hold Rating, Announces Price Target of $415
Analysts Offer Insights on Healthcare Companies: Medpace Holdings (MEDP) and Roche Holding AG (OtherRHHVF)
Medpace Holdings Price Target Cut to $430.00/Share From $469.00 by Baird
A Quick Look at Today's Ratings for Medpace(MEDP.US), With a Forecast Between $430 to $480
Deutsche Bank Adjusts Medpace Holdings Price Target to $336 From $395, Maintains Hold Rating